https://doi.org/10.1038/s41467-024-49595-1
N
Nicholas R. Fernandez
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
43
Papers
214
Citations
6
h-index
6
i10-index
Nicholas R. Fernandez is an academic researcher. The author has contributed to research in topics: Glioma Diagnosis and Treatment & Cancer Immunotherapy and Biomarkers & Cancer, Stress, Anesthesia, and Immune Response. The author has an h-index of 6, co-authored 37 publications.
ORCID: 0000-0003-4844-261XPapers by this author
worksImmuno-oncologic profiling of pediatric brain tumors reveals major clinical significance of the tumor immune microenvironment
2024 · Nature Communications · 28 citations
The landscape of primary mismatch repair deficient gliomas in children, adolescents, and young adults: a multi-cohort study
2024 · The Lancet Oncology · 14 citations
https://doi.org/10.1016/s1470-2045(24)00640-5
Figure 6 from Combined Immunotherapy Improves Outcome for Replication-Repair-Deficient (RRD) High-Grade Glioma Failing Anti–PD-1 Monotherapy: A Report from the International RRD Consortium
2024 · 0 citations
https://doi.org/10.1158/2159-8290.25183898
Data from Combined Immunotherapy Improves Outcome for Replication-Repair-Deficient (RRD) High-Grade Glioma Failing Anti–PD-1 Monotherapy: A Report from the International RRD Consortium
2024 · 0 citations
https://doi.org/10.1158/2159-8290.c.7065317.v1
Table S2 from Combined Immunotherapy Improves Outcome for Replication-Repair-Deficient (RRD) High-Grade Glioma Failing Anti–PD-1 Monotherapy: A Report from the International RRD Consortium
2024 · 0 citations
https://doi.org/10.1158/2159-8290.25183886
Table S2 from Combined Immunotherapy Improves Outcome for Replication-Repair-Deficient (RRD) High-Grade Glioma Failing Anti–PD-1 Monotherapy: A Report from the International RRD Consortium
2024 · 0 citations
https://doi.org/10.1158/2159-8290.25183886.v1
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat